Clinical Trial Update: Radiotherapy Alone Versus Concurrent Chemoradiation in Low Risk NK/T-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating radiotherapy alone versus concurrent chemoradiation for low-risk Extranodal NK/T-cell Lymphoma, Nasal Type, was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Snippet

Sponsor: Fudan University | Conditions: Extranodal NK/T-cell Lymphoma, Nasal Type | Phase 2 | Status: TERMINATED